Centene’s stock pulled a sharp U-turn into the green, after the health insurer helped assuage investor worries by providing details on its full-year outlook, and by suggesting the worst will pass soon.

The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE:CNC) saw its stock tumble significantly on Friday after reporting a surprising second-quarter 2025 adjusted loss of 16 cents per share.

Health coverage company Centene (NYSE:CNC) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 22.4% year on year to $48.74 billion. Its non-GAAP loss of $0.16 per share was significantly below analysts’ consensus estimates.

Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety over government-sponsored healthcare.

In its second quarter, the Clayton-based company lost $253 million dollars, 51 cents a share. In the same period last year, Centene saw earnings of $2.26 a share.

Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription Drug segments outperform expectations. Learn more on CNC stock here.

In the case of Centene, which is trading at $34.57 as of publishing time, $100 would buy you 2.89 shares of stock. If you're looking to bet against a company, the process is more complex.

Intel (NASDAQ: INTC) stock slumped 8% after the chipmaker forecast steeper losses than expected in the third quarter and announced plans to slash jobs, reducing headcount to 75,000 by the end of year, down 22% from the end of 2024, which will be through attrition and "other means".

Centene is trading at half of book value and under 9x earnings, an extreme undervaluation for a cash-generating insurer. See why I rate CNC stock a Buy.